Market Cap: $14.19B
BI
BridgeBio Pharma, Inc.
BBIO
NASDAQ (NASDAQ Global Select)USD
Market Cap: $14.19B
Analysts estimated BBIO earnings of $-0.60 per share this quarter (Q2). BBIO's actual earnings were $-0.78 per share.
BBIO EPS surprise of -31.07%Analysts estimated BBIO earnings of $-0.69 per share this quarter (Q1). BBIO's actual earnings were $-0.84 per share.
BBIO EPS surprise of -21.37%Analysts estimated BBIO earnings of $-0.76 per share this quarter (Q4). BBIO's actual earnings were $-1.00 per share.
BBIO EPS surprise of -32.10%Analysts estimated BBIO earnings of $-0.89 per share this quarter (Q3). BBIO's actual earnings were $-0.95 per share.
BBIO EPS surprise of -6.16%Analysts estimated BBIO earnings of $-0.86 per share this quarter (Q2). BBIO's actual earnings were $-0.95 per share.
BBIO EPS surprise of -10.44%Analysts estimated BBIO earnings of $-0.94 per share this quarter (Q1). BBIO's actual earnings were $-0.88 per share.
BBIO EPS surprise of 6.56%Analysts estimated BBIO earnings of $-1.15 per share this quarter (Q4). BBIO's actual earnings were $-1.40 per share.
BBIO EPS surprise of -21.38%Analysts estimated BBIO earnings of $-1.00 per share this quarter (Q3). BBIO's actual earnings were $-1.10 per share.
BBIO EPS surprise of -10.21%Analysts estimated BBIO earnings of $-1.09 per share this quarter (Q2). BBIO's actual earnings were $-0.39 per share.
BBIO EPS surprise of 64.07%Analysts estimated BBIO earnings of $-0.73 per share this quarter (Q1). BBIO's actual earnings were $-0.20 per share.
BBIO EPS surprise of 72.47%Analysts estimated BBIO earnings of $-0.93 per share this quarter (Q4). BBIO's actual earnings were $-0.96 per share.
BBIO EPS surprise of 3.37%